| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| BEST Inc. (TBA) | Citigroup/ Credit Suisse/ Goldman Sachs/ J.P. Morgan/ Deutsche Bank | $750.00 | n.a. | |||
| Clementia Pharmaceuticals (CMTA) | Morgan Stanley/ Leerink Partners | $115.00 | n.a. | |||
| Industrea Acquisition (INDUU) (u) | FBR/ B. Riley & Co. | 20.00 | $10.00 | $10.00 | $200.00 | n.a. |
| Osprey Energy Acquisition (OSPRU) (u) | Credit Suisse | 25.00 | $10.00 | $10.00 | $250.00 | n.a. |
| RBB Bancorp (TBA) | Sandler O’Neill/ Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | $82.80 | n.a. | |||
| Redfin (RDFN) | Goldman Sachs/ Allen & Company/ BofA Merrill Lynch/ RBC Capital Markets | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Blue Apron Holdings (APRN) | Goldman Sachs/ Morgan Stanley/ Citigroup/ Barclays | 30.00 | $10.00 | $11.00 | $315.00 | S/O |
| Dole Food Company (DOLE) | Morgan Stanley/ BofA Merrill Lynch/ Deutsche Bank Securities/ RBC Capital Markets | $100.00 | S/O | |||
| Gadsden Growth Properties (GADS) | National Securities Corporation | 5.00 | $9.00 | $11.00 | $50.00 | S/O |
| Venator Materials PLC (VNTR) | BofA Merrill Lynch/ Goldman Sachs/ BofA Merrill Lynch/ J.P. Morgan | $100.00 | S/O | |||
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of June 26, 2017 | Manager(s) | Offered | Raised | Price | 6/30/17 | Change |
| Avenue Therapeutics (ATXI) | Oppenheimer | 5.50 | $33.00 | $6.00 | $7.95 | 32.50% |
| Dova Pharmaceuticals (DOVA) | J.P. Morgan/ Jefferies/ Leerink Partners | 4.42 | $75.06 | $17.00 | $22.29 | 19.81% |
| Esquire Financial Holdings (ESQ) | Sandler O’Neill & Partners | 2.36 | $33.09 | $14.00 | $15.00 | 7.14% |
| Byline Bancorp (BY) | BofA Merrill Lynch/ Keefe, Bruyette & Woods (A Stifel Company) | 5.70 | $108.30 | $19.00 | $20.05 | 5.53% |
| Tintri (TNTR) | Morgan Stanley/ BofAMerrill Lynch/ Pacific Crest Securities (a division of KeyBanc Capital Markets) | 8.57 | $60.00 | $7.00 | $7.27 | 3.86% |
| TPG Pace Holdings (TPGH.U) (u) | Deutsche Bank Securities/ Goldman Sachs | 40.00 | $400.00 | $10.00 | $10.26 | 2.60% |
| Blue Apron Holdings (APRN) | Goldman Sachs/ Morgan Stanley/ Citigroup/ Barclays | 30.00 | $300.00 | $10.00 | $9.34 | -6.60% |
| Mersana Therapeutics (MRSN) | J.P. Morgan/ Cowen/ Leerink Partners | 5.00 | $75.00 | $15.00 | $13.97 | -6.87% |
| Aileron Therapeutics (ALRN) | BofA Merrill Lynch/ Jefferies | 3.75 | $52.50 | $14.00 | $11.15 | -20.36% |
| u (unit offering) | ||||||
